Retinoblastoma — Trials

Retinoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 8
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: Institut Curie
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04681417	Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome(RETINO 2018)	recruiting	Phase 2 / Phase 3	225	Institut CurieOTHER	1	Nov 28, 2025	clinicaltrials
NCT05080010	Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma	recruiting	Phase 3	500	Sun Yat-sen UniversityOTHER	1	Oct 15, 2021	clinicaltrials